title: Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
abstract: An aspartate residue corresponding to aspartate-80 of dopamine D2 receptors is strictly conserved among receptors that couple to guanine nucleotide-binding proteins. Mutation of this residue alters the function of several classes of neurotransmitter receptors. Dopamine D2 receptors couple to the guanine nucleotide-binding protein Gi to inhibit adenylyl cyclase (ATP-pyrophosphate-lyase, cyclizing; EC 4.6.1.1). Like other Gi-coupled receptors, the binding of agonists and some antagonists to D2 receptors is sensitive to pH and sodium. In the present report, we demonstrate that substitution of an alanine or glutamate residue for aspartate-80 severely impairs inhibition of adenylyl cyclase by D2 receptors and also abolishes or decreases the regulation of the affinity of D2 receptors for agonists and substituted benzamide antagonists by sodium and pH. Our data support the hypothesis that the conformation of D2 receptors is maintained by interactions of monovalent cations with aspartate-80. The regulation of D2 receptors by this interaction has important consequences for the affinity of D2 receptors for ligands and for signal transduction by D2 receptors.
authors.affiliation: Medical Research Service, VA Medical Center, Portland, Oregon.
authors.forename: K A
authors.initials: KA
authors.lastname: Neve
authors.forename: B A
authors.initials: BA
authors.lastname: Cox
authors.forename: R A
authors.initials: RA
authors.lastname: Henningsen
authors.forename: A
authors.initials: A
authors.lastname: Spanoyannis
authors.forename: R L
authors.initials: RL
authors.lastname: Neve
mesh_terms: D000067956:Adenylyl Cyclase Inhibitors; D000595:Amino Acid Sequence; D001224:Aspartic Acid / Q000502:physiology*; D001549:Benzamides / Q000378:metabolism; D005033:Ethylmaleimide / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008969:Molecular Sequence Data; D009154:Mutation; D011487:Protein Conformation; D011759:Pyrrolidines / Q000378:metabolism; D011869:Radioligand Assay; D011954:Receptors, Dopamine / Q000032:analysis / Q000502:physiology*; D017448:Receptors, Dopamine D2; D012964:Sodium / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D001549:Benzamides; D011759:Pyrrolidines; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; C063525:epidepride; D001224:Aspartic Acid; D012964:Sodium; D005033:Ethylmaleimide